2020
DOI: 10.1111/imj.14785
|View full text |Cite
|
Sign up to set email alerts
|

Author reply

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 7 publications
0
4
0
Order By: Relevance
“…3 A recent meta-analysis suggests that the caution regarding simvastatin dosing in the presence of this variant also applies to rosuvastatin. 5 Examination of Pharmaceutical Benefits Scheme for the year 2018 showed that simvastatin and rosuvastatin accounted for 18% and 29% (respectively) of all statins dispensed in Australia (http://medicarestatistics.humanservices.gov. au/statistics/pbs_item.jsp).…”
Section: Letters To the Editormentioning
confidence: 99%
See 2 more Smart Citations
“…3 A recent meta-analysis suggests that the caution regarding simvastatin dosing in the presence of this variant also applies to rosuvastatin. 5 Examination of Pharmaceutical Benefits Scheme for the year 2018 showed that simvastatin and rosuvastatin accounted for 18% and 29% (respectively) of all statins dispensed in Australia (http://medicarestatistics.humanservices.gov. au/statistics/pbs_item.jsp).…”
Section: Letters To the Editormentioning
confidence: 99%
“…While the SLCO1B1 gene is by far the most robustly associated variant with SAMS, an increasing array of genetic variants is also reported to be associated with SAMS phenotypes. 5 A predisposing genetic polymorphism will increase the risk of an event, such as SAMS, but the vast majority of people with a high-risk polymorphism will still not develop the event. 6 Conversely, people without a highrisk polymorphism may still develop the condition.…”
Section: Author Replymentioning
confidence: 99%
See 1 more Smart Citation
“…[11,12] Although statins are generally well tolerated with relatively few adverse reactions, and their clinical application and research scope have expanded accordingly, [13] statin-induced toxic side effects are an emerging concern. [14] Hepatotoxicity and myotoxicity are the most common severe adverse reactions to statins in the clinical setting, although the mechanisms of these toxicities are not well understood. [15,16] Interestingly, statins have been found to be toxic to many cells examined in vitro, including brain, lung, intestinal, C2C12, H9c2, and liver cells.…”
mentioning
confidence: 99%